Craft
Royal DSM

Royal DSM

Suppliers

35 K

FY, 2018

Revenue

€9.2 B

FY, 2021

Market Capitalization

€20 B

2022-09-19

Royal DSM Summary

Company summary

Overview
Royal DSM is a science-based company engaged in nutrition, health, and sustainable living. It delivers business solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. The company operates through three segments: Nutrition, Materials, and Innovation Center. The Nutrition segment provides solutions for animal feed, food and beverages, pharmaceuticals, early life nutrition, nutrition improvement, dietary supplements, and personal care. The Materials segment provides fiber solutions, high-performance plastics, and resins solutions. The Innovation Center segment develops biomedical, solar, and bio-based products and services.
Type
Public
Founded
1902
HQ
Heerlen, NL | view all locations
Website
https://www.dsm.com/corporate/home.html
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Geraldine Matchett

    Geraldine Matchett, Co-CEO and Member of Managing Board

  • Dimitri-de Vreeze

    Dimitri-de Vreeze, Co-CEO and Member of the Managing Board

  • Eric V. Shelton

    Eric V. Shelton, VP, Global Marketing and Sales

  • Gemma Isherwood

    Gemma Isherwood, Senior Director, Global People and Organization, Global Head of HR DSM Biomedical and DSM Group Science & Innovation

Operating MetricsView all

Patent Applications Filed Yearly

397
40.8%

FY, 2018

Suppliers

35K
2.9%

FY, 2018

Countries (Facilities)

40

FY, 2018

LocationsView all

237 locations detected

  • Heerlen, Limburg HQ

    Netherlands

    1 Het Overloon

  • Ames, IA

    United States

    616 Dayton Ave

  • Arcadia, WI

    United States

    501 S Washington St

  • Belvidere, NJ

    United States

    200 Roche Dr

  • Berkeley, CA

    United States

    2840 Seventh St

  • Boulder, CO

    United States

    4909 Nautilus Ct. N Suite 230

and 231 others

Royal DSM Financials

Summary financials

Revenue (H1, 2022)
€4.1B
Gross profit (H1, 2022)
€1.4B
Net income (H1, 2022)
€287.0M
Cash (H1, 2022)
€792.0M
EBIT (H1, 2022)
€398.0M
Enterprise value
$22.3B

Footer menu